Federation des caisses Desjardins du Quebec’s ClearPoint Neuro CLPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.64K Buy
950
+550
+138% +$6.95K ﹤0.01% 2368
2025
Q4
$5.47K Sell
400
-25
-6% -$463 ﹤0.01% 2426
2025
Q3
$9.26K Buy
425
+380
+844% +$4.48K ﹤0.01% 2289
2025
Q2
$537 Buy
45
+15
+50% +$189 ﹤0.01% 2565
2025
Q1
$357 Buy
30
+5
+20% +$78 ﹤0.01% 2528
2024
Q4
$385 Buy
+25
New +$324 ﹤0.01% 2411
2024
Q3
Sell
-8,000
Closed -$43.1K 2593
2024
Q2
$43.1K Buy
8,000
+2,000
+33% +$11.6K ﹤0.01% 1421
2024
Q1
$40.8K Buy
+6,000
New +$41.9K ﹤0.01% 1464

Other funds holding CLPT

Federation des caisses Desjardins du Quebec's CLPT Position: Q1 2026 in Review

Federation des caisses Desjardins du Quebec increased its ClearPoint Neuro (CLPT) stake by 138% in Q1 2026, buying an estimated $6.95K and bringing the position to 950 shares worth $8.64K. The position accounts for ﹤0.01% of the portfolio, ranked #2368.

Federation des caisses Desjardins du Quebec first reported a position in CLPT in Q1 2024 and has held it in 8 quarters since. The position peaked at $43.1K in Q2 2024. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

  • Federation des caisses Desjardins du Quebec held 950 shares of ClearPoint Neuro worth $8.64K as of Q1 2026.
  • Federation des caisses Desjardins du Quebec bought 550 ClearPoint Neuro shares in Q1 2026, an estimated $6.95K.
  • ClearPoint Neuro made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q1 2026, its #2368 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in ClearPoint Neuro in Q1 2024 and has held it in 8 quarters since.
  • Federation des caisses Desjardins du Quebec's ClearPoint Neuro position peaked at $43.1K in Q2 2024.
  • 118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.